Marex Group’s Bristol-Myers Squibb BMY Stock Holding History

Marex Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$332K	Sell	5,477 -1,382	-20%	-$80.6K	﹤0.01%	740
2025 Q4	$370K	Buy	+6,859	New	+$330K	﹤0.01%	648
2025 Q3	–	Sell	-12,772	Closed	-$591K	–	866
2025 Q2	$591K	Sell	12,772 -120,684	-90%	-$5.92M	0.01%	357
2025 Q1	$8.14M	Sell	133,456 -2,917	-2%	-$170K	0.16%	80
2024 Q4	$7.71M	Buy	136,373 +132,327	+3,271%	+$7.39M	0.13%	79
2024 Q3	$209K	Sell	4,046 -1,878	-32%	-$88.1K	﹤0.01%	473
2024 Q2	$246K	Buy	+5,924	New	+$265K	0.01%	463
2024 Q1	–	Sell	-6,242	Closed	-$320K	–	532
2023 Q4	$320K	Buy	+6,242	New	+$328K	0.01%	377
2023 Q1	–	Sell	-7,507	Closed	-$540K	–	266
2022 Q4	$540K	Buy	+7,507	New	+$566K	0.08%	160

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marex Group's BMY Position: Q1 2026 in Review

Marex Group reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, selling an estimated $80.6K and leaving 5,477 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Marex Group first reported a position in BMY in Q4 2022 and has held it in 9 quarters since. The position peaked at $8.14M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Marex Group held 5,477 shares of Bristol-Myers Squibb worth $332K as of Q1 2026.
Marex Group sold 1,382 Bristol-Myers Squibb shares in Q1 2026, an estimated $80.6K.
Bristol-Myers Squibb made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #740 holding.
Marex Group first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 9 quarters since.
Marex Group's Bristol-Myers Squibb position peaked at $8.14M in Q1 2025.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.